BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22729368)

  • 1. Inhibition of phosphoinositide 3-kinase enhances the cytotoxicity of AG1478, an epidermal growth factor receptor inhibitor, in breast cancer cells.
    Li P; Torossian A; Zhang Q; Xu WC; Fu S
    Med Oncol; 2012 Dec; 29(5):3258-64. PubMed ID: 22729368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
    Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells.
    Li P; Veldwijk MR; Zhang Q; Li ZB; Xu WC; Fu S
    BMC Cancer; 2013 Jun; 13():297. PubMed ID: 23777562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells.
    Yu Y; Zhang M; Zhang X; Cai Q; Hong S; Jiang W; Xu C
    J Hematol Oncol; 2014 May; 7():39. PubMed ID: 24886678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
    Meng X; Hu B; Hossain MM; Chen G; Sun Y; Zhang X
    Int J Oncol; 2016 Aug; 49(2):682-90. PubMed ID: 27221510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.
    Axanova LS; Chen YQ; McCoy T; Sui G; Cramer SD
    Prostate; 2010 Nov; 70(15):1658-71. PubMed ID: 20583132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M; Esmaeili-Mahani S
    Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of luteolin on the proliferation of human breast cancer cell lines induced by epidermal growth factor.
    Sui JQ; Xie KP; Xie MJ
    Sheng Li Xue Bao; 2016 Feb; 68(1):27-34. PubMed ID: 26915319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
    She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
    BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of epidermal growth factor receptor-mediated β-catenin nuclear accumulation enhances the anti-tumor activity of phosphoinositide 3-kinase inhibitor in breast cancer.
    Niu J; Wang X; Liang C; Zhang YD; Liu FY; Li HY; Xie SQ; Sun H; Fang D
    Cell Biol Int; 2019 Aug; 43(8):931-939. PubMed ID: 31124219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
    Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
    Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence and mechanism of 5-aminolevulinic acid-photodynamic therapy on the metastasis of esophageal carcinoma.
    Zhang X; Cai L; He J; Li X; Li L; Chen X; Lan P
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():78-85. PubMed ID: 28811223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling.
    She QB; Solit D; Basso A; Moasser MM
    Clin Cancer Res; 2003 Oct; 9(12):4340-6. PubMed ID: 14555504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.
    Maiello MR; D'Alessio A; De Luca A; Carotenuto A; Rachiglio AM; Napolitano M; Cito L; Guzzo A; Normanno N
    Breast Cancer Res Treat; 2007 May; 102(3):275-82. PubMed ID: 17004112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
    Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
    Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.
    Wu Z; Gioeli D; Conaway M; Weber MJ; Theodorescu D
    Prostate; 2008 Jun; 68(9):935-44. PubMed ID: 18386291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanism of erlotinib resistance in epidermal growth factor receptor mutant non-small cell lung cancer cell line H1650].
    Han R; Wang X; Zhong D; Zhao J; Chen Z; Sun L; Wang J; Zhang J
    Zhongguo Fei Ai Za Zhi; 2012 Dec; 15(12):689-93. PubMed ID: 23249714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
    Baba Y; Maeda T; Suzuki A; Takada S; Fujii M; Kato Y
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.